Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

This document is a response-to-comments article regarding the proposed policy on amniotic and placental derived product injections/applications for non-wound musculoskeletal indications; it does not itself define coverage, limitations, documentation requirements, or frequency limits. No actionable coverage criteria were provided in the text supplied; review of the underlying proposed and final policy texts is required to determine specific Medicare coverage rules.